Trexquant Investment LP Glaukos Corp Transaction History

Trexquant Investment LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$59.53 - $85.11 $443,379 - $633,899	7,448 Added 34.92%	28,779 $2.29 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $1 Million - $1.14 Million	14,467 Added 210.77%	21,331 $1.61 Million
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $311,900 - $488,785	6,864 New	6,864 $488,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $199,444 - $249,050	4,258 New	4,258 $227,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $292,682 - $414,203	-7,268 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $344,721 - $612,183	7,268 New	7,268 $350,000
Q3 2019 Nov 08, 2019	SELL	$58.58 - $83.91 $660,196 - $945,665	-11,270 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$63.59 - $78.71 $716,659 - $887,061	11,270 New	11,270 $850,000
Q4 2018 Feb 13, 2019	SELL	$52.18 - $67.93 $976,496 - $1.27 Million	-18,714 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$38.13 - $68.37 $713,564 - $1.28 Million	18,714 New	18,714 $1.22 Million
Q1 2018 May 03, 2018	SELL	$26.05 - $34.5 $1.04 Million - $1.38 Million	-39,926 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$24.5 - $36.01 $978,187 - $1.44 Million	39,926	39,926 $1.02 Million

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.